금융 뉴스 허브

Quanta's 65% YTD Surge: Can Infrastructure Demand Fuel More Gains?

Can PWR's record $53.4B backlog, strong infrastructure demand and rising earnings fuel further gains after its 64.6% YTD rally despite a premium valuation?

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks:Stock Name Volume High Low Last Change Alaunos Therapeutics Inc.

3 Reasons to Avoid VAL and 1 Stock to Buy Instead

Over the past six months, Valaris’s shares (currently trading at $84.73) have posted a disappointing 14.5% loss, well below the S&P 500’s 13.5% gain. This may have investors wondering how to approach ...

Can Chipotle Stock Bounce Off The Current Support?

Shares of Chipotle Mexican Grill (CMG) have lost 23% over the past twelve months, while the S&P 500 gained about 18%. The decline has brought the shares back to about $30, a price they have bounced fr ...

The Dow's Bank Earnings Boost Didn't Last Long

The Dow Jones Industrial Average’s bank earnings boost didn’t last long.

Who should pay for a birthday dinner? I always treat my guests.

“I feel like I just end up paying for other people’s birthday dinners a lot, as well as my own, which is an imbalance.”

What Did Dell Stock Investors Miss Before The Run?

Shares of Dell Technologies (DELL) returned 274.5% in the twelve months to October 12, 2026, easily outpacing the 17.3% return for the S&P 500. That climb centered on servers, particularly the hardwar ...

Why one hedge-fund billionaire believes stocks are heading for a ‘really challenging’ 2027

U.S. stocks could face a serious test in 2027 as a tsunami of new equity issuance threatens to upend the artificial-intelligence-driven bull market, according to hedge-fund billionaire Paul Tudor Jone ...

Small-Business Optimism Dips in September

Small-Business Optimism Dips in September.

Existing home sales unexpectedly rise in September

3 Reasons FOXA is Risky and 1 Stock to Buy Instead

Since April 2026, FOX has been in a holding pattern, floating around $62.59. The stock also fell short of the S&P 500’s 13.5% gain during that period.

Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms

VEEV's push into early-stage biotech could unlock long-term revenue opportunities as its streamlined software solutions simplify critical drug development processes.